Rab22a-NeoF1: a promising target for osteosarcoma patients with lung metastasis
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research has identified Rab22a-NeoF1 as a potential target for treatment of osteosarcoma patients who have developed lung metastasis. This development may offer new hope for patients with this specific condition. The identification of Rab22a-NeoF1 as a target suggests it could be used to develop therapies for osteosarcoma with lung metastasis.